Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suhu Liu

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Oncotarget|July 21, 2016
Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemiaKamilla M E Laidlaw, Samuel Berhan, Suhu Liu, et al.
Science Signaling|January 30, 2014
STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypesMichael Xiang, Nicolai J Birkbak, Vida Vafaizadeh, et al.
BMC Medical Genomics|April 30, 2008
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasisAdam I Riker, Steven A Enkemann, Oystein Fodstad, et al.
Blood Advances|December 4, 2018
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapySuhu Liu, Anna E Marneth, Gabriela Alexe, et al.
Oncogenesis|February 24, 2019
Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenograftsChun-Hau Chen, Swati Bhasin, Prateek Khanna, et al.
Journal of Medicinal Chemistry|August 11, 2015
Development of Selective Covalent Janus Kinase 3 InhibitorsLi Tan, Koshi Akahane, Randall McNally, et al.
Blood|August 18, 2016
Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agentMichael Xiang, Haesook Kim, Vincent T Ho, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Oncotarget|July 21, 2016
Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemiaKamilla M E Laidlaw, Samuel Berhan, Suhu Liu, et al.
Science Signaling|January 30, 2014
STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypesMichael Xiang, Nicolai J Birkbak, Vida Vafaizadeh, et al.
BMC Medical Genomics|April 30, 2008
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasisAdam I Riker, Steven A Enkemann, Oystein Fodstad, et al.
Blood Advances|December 4, 2018
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapySuhu Liu, Anna E Marneth, Gabriela Alexe, et al.
Oncogenesis|February 24, 2019
Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenograftsChun-Hau Chen, Swati Bhasin, Prateek Khanna, et al.
Journal of Medicinal Chemistry|August 11, 2015
Development of Selective Covalent Janus Kinase 3 InhibitorsLi Tan, Koshi Akahane, Randall McNally, et al.
Blood|August 18, 2016
Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agentMichael Xiang, Haesook Kim, Vincent T Ho, et al.
Pageof 3